Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
"He thinks his contract with Lekrone is for the 1st 15% total revenue."
I don't think Chuck has ever said that. What he's said is that PTSC allowed TPL to strike a deal whereby TPL got the 1st 15% of total revenue. Chuck has stated that he's got an agreement to split TPL's half of the resultant profit from the remaining 85% of the revenue, not of the first 15% of the revenue.
